1236471-A2 is referenced by 19 patents and cites 20 patents.

Angiostatic steroids for use in controlling neovascularization and ocular hypertension are disclosed. Pharmaceutical compositions of the angiostatic steroids and methods for their use in treating neovascularization and ocular hypertension, including controlling the ocular hypertension associated with primary open angle glaucoma, are disclosed. In addition, the combination of the compounds with glucocorticoids for the prevention of elevated intraocular pressure during the treatment of inflammation is disclosed.

Title
Angiostatic steroids
Application Number
EP20020009993 19921123
Publication Number
1236471 (A2)
Application Date
November 23, 1992
Publication Date
September 4, 2002
Inventor
Conrow Raymond E
US
Clark Abbot F
US
Assignee
Alcon Lab
US
IPC
C07J 51/00
C07J 41/00
C07J 11/00
C07J 09/00
C07J 05/00
C07J 03/00
A61K 31/57
A61K 31/56
A61K 31/565
C07J 51/00
C07J 41/00
C07J 11/00
C07J 09/00
C07J 05/00
C07J 03/00
A61K 31/665
A61K 31/58
A61K 31/57
A61K 31/565
A61K 31/56
C07J 51/00
C07J 41/00
C07J 11/00
C07J 09/00
C07J 05/00
C07J 03/00
A61K 31/665
A61K 31/58
A61K 31/57
A61K 31/565
A61K 31/56
View Original Source Download PDF